Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MK 0852

Known as: MK 852, MK-852, MK-0852 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
The effects of the GPIIb-IIIa antagonists abciximab and MK-852 on platelet-leukocyte interactions in vitro were studied and the… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2003
2003
This study was to investigate the appearance of P-selectin, tissue factor (TF) and CD40 ligand (CD40L) on platelet-leucocyte… Expand
Is this relevant?
2002
2002
We have studied the contribution of platelets to the coagulation of plasma and the effects of activation or inhibition of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1998
1998
Platelet activation is accompanied by changes in the composition of the platelet cytoskeleton with rapid incorporation and… Expand
Is this relevant?
1998
1998
A critical function of fibrinogen in hemostasis and thrombosis is to mediate platelet aggregation by binding selectively to an… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1998
1998
Platelets in stirred whole blood can be induced to form aggregates and also to form heterotypic platelet-monocyte (P/M) and… Expand
Is this relevant?
1998
1998
BACKGROUND Citrated platelet-rich plasma (PRP) turbidimetry is used for assessing pharmacodynamic effects of glycoprotein (GP… Expand
  • figure 1
  • figure 2
  • table 2
  • table 1
Is this relevant?
1998
1998
Conformational activation of platelet GpIIb/IIIa which is coupled to increased affinity for binding of soluble fibrinogen is an… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1995
1995
BACKGROUND Thrombin inhibitors have been shown to be efficacious in animal models of thrombosis and in initial human clinical… Expand
Is this relevant?
1993
1993
The antiaggregatory and antithrombotic actions of MK-0852, a cyclic heptapeptide antagonist of the platelet GP IIb/IIIa, were… Expand
Is this relevant?